← Leaderboards
Yuying Tan
Anticancer, Inc.
$1,577,106
Attributed
$1,577,106
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,577,106 · 4
By mechanism
R44$915,036 · 1
R43$662,070 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Recombinant Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$132,165,789
- Barton F Haynes · Duke University$119,908,001
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Larry Arthur$44,832,982
- John P Moore · Weill Medical College Of Cornell Univ$36,733,380
- Wayne A. Hendrickson · Rutgers The St Univ Of Nj New Brunswick$34,072,238
Research focus
Recombinant ProteinsCarbon Sulfur LyaseAntineoplasticsLaboratory MouseDrug Screening /EvaluationHigh Performance Liquid ChromatographyCardiovascular Disorder DiagnosisPharmacokineticsPolyethylene GlycolsBioassayProtein EngineeringClinical ChemistryTechnology /Technique DevelopmentEnzyme ActivityColon NeoplasmsEther HydrolaseDiagnostic TestsGuinea PigsHigh Throughput TechnologyHomocysteineHuman TissueLung NeoplasmsMethionineTransfection /Expression Vector
Grant awards (6)
Enzyme therapy for hyperhomocysteinemia$149,800
R43 · FY2005 · HL
RHOMOCYCSTEINASE FOR HOMOCYSTEINE ASSAY$451,736
R44 · FY2002 · HL
RHOMOCYSTEINASE FOR HOMOCYSTEINE ASSAY$463,300
R44 · FY2001 · HL
NEW PEGYLATED MOLECULES OF RECOMBINANT METHIONINASE$192,850
R43 · FY2001 · CA
NEW PEGYLATED MOLECULES OF RECOMBINANT METHIONINASE$219,420
R43 · FY2000 · CA
SYNERGISTIC METHIONINASE GENE THERAPY OF CANCER$100,000
R43 · FY2000 · CA